Literature DB >> 33972048

COVID-19: The experience from Iran.

Maryam Daneshpazhooh1, HamidReza Mahmoudi2.   

Abstract

The first cases of coronavirus disease 2019 (COVID-19) in Iran were detected on February 19, 2020. Soon the entire country was hit with the virus. Although dermatologists were not immediately the frontline health care workers, all aspects of their practice were drastically affected. Adapting to this unprecedented crisis required urgent appropriate responses. With preventive measures and conserving health care resources being the most essential priorities, dermatologists, as an integral part of the health system, needed to adapt their practices according to the latest guidelines. The spectrum of the challenges encompassed education, teledermatology, lasers, and other dermatologic procedures, as well as management of patients who were immunosuppressed or developed drug reactions and, most importantly, the newly revealed cutaneous signs of COVID-19. These challenges have paved the way for new horizons in dermatology.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33972048     DOI: 10.1016/j.clindermatol.2020.12.009

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  4 in total

Review 1.  Teledermatology During COVID-19: An Updated Review.

Authors:  Morgan A Farr; Madeleine Duvic; Tejas P Joshi
Journal:  Am J Clin Dermatol       Date:  2021-04-09       Impact factor: 6.233

2.  COVID-19 and urban rivers: Effects of lockdown period on surface water pollution and quality- A case study of the Zarjoub River, north of Iran.

Authors:  Hamed Haghnazar; Jeffrey A Cunningham; Vinod Kumar; Ehsan Aghayani; Mojtaba Mehraein
Journal:  Environ Sci Pollut Res Int       Date:  2022-01-03       Impact factor: 5.190

3.  Proposing a novel deep network for detecting COVID-19 based on chest images.

Authors:  Maryam Dialameh; Ali Hamzeh; Hossein Rahmani; Amir Reza Radmard; Safoura Dialameh
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

4.  Adverse outcome and severity of COVID-19 in patients with autoimmune bullous diseases: A historical cohort study.

Authors:  Fateme Shirzad Moghadam; Nika Kianfar; Shayan Dasdar; Rana Samii; Zeinab Farimani; Pedram Molhem Azar; Kamran Balighi; Robabeh Abedini; Tahereh Soori; Ali Salehi Farid; Hamidreza Mahmoudi; Maryam Daneshpazhooh
Journal:  Dermatol Ther       Date:  2022-07-21       Impact factor: 3.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.